NUR-SULTAN: Kazakhstan’s Prime Minister Askar Mamin visited the Research Institute for Biological Safety Problems of the Ministry of Education and Science in the village of Gvardeisky, Korday district, Zhambyl region, where the first volunteers were vaccinated with the domestic vaccine against COVID-19.
To date, the research institute has conducted phase I and II clinical trials of the domestic vaccine QazCovid-in. Preliminary research results have demonstrated high safety, immunogenicity and efficacy of the vaccine at 96%.
The Kazakh Ministry of Healthcare has approved the start of the final, phase III clinical trials on 3,000 volunteers. On December 19, the first volunteers were vaccinated with the domestic vaccine at the research institute and in clinics in Almaty and Taraz.
By the end of December 2020, the vaccination of three thousand volunteers will be completed. For phase III, the required batch of vaccine in the amount of 10 thousand doses will be produced.
“Mass vaccination with the domestic vaccine will begin in March 2021. First of all, medical workers, teachers, as well as representatives of risk groups with chronic diseases will be vaccinated on a voluntary basis,” Prime Minister Mamin said.
The prime minister inspected the construction of a biopharmaceutical plant for the production of vaccines. The plant is scheduled to be commissioned in March 2021. The production capacity will be 60 million doses per year. – Agencies
